Citation Impact
Citing Papers
Comparison of Effects of the Bisphosphonate Alendronate Versus the RANKL Inhibitor Denosumab on Murine Fracture Healing
2008
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Abnormal Regulation of the Sympathetic Nervous System in α2A-Adrenergic Receptor Knockout Mice
1999 StandoutNobel
Orally active growth hormone secretagogues: state of the art and clinical perspectives
1998
Higher Incidence of Osteonecrosis of the Jaw (ONJ) in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Anti-Angiogenic Agents
2009
Visible light photoredox catalysis: applications in organic synthesis
2010 Standout
Contribution of lymphatic transport to the systemic exposure of orally administered moxidectin in conscious lymph duct-cannulated dogs
2005
Specific angiotensin II receptor blockade improves intestinal perfusion during graded hypovolemia in pigs
2000
Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis
2007
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1999 Standout
Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering
2006 Standout
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
Catalysis for fluorination and trifluoromethylation
2011 StandoutNature
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
2008
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Involvement of peripheral presynaptic inhibition in the reduction of sympathetic tone by moxonidine, rilmenidine and UK 14304
1995
Triptans in Migraine
2000
Randomized Trial of Effect of Alendronate Continuation Versus Discontinuation in Women With Low BMD: Results From the Fracture Intervention Trial Long-Term Extension
2004
Central sensitization: Implications for the diagnosis and treatment of pain
2010 Standout
Pharmacology of bisphosphonates
2011
Intervention thresholds for osteoporosis
2002
Short-term effects of transdermal nicotine on acute tissue plasminogen activator release in vivo in man
2001
Abnormal Regulation of the Sympathetic Nervous System in α2A-Adrenergic Receptor Knockout Mice
1999 StandoutNobel
Radiosyntheses using Fluorine-18: The Art and Science of Late Stage Fluorination
2014
Effect of Obesity and Feeding on the Growth Hormone (GH) Response to the GH Secretagogue L-692,429 in Young Men1
1997
Visible light photocatalysis as a greener approach to photochemical synthesis
2010 Standout
Fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting
2012
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
2003 Standout
Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: A comparison to other agents
2008
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Neuroimaging of the Brain-Gut Axis: From Basic Understanding to Treatment of Functional GI Disorders
2006
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
2004 Standout
Growth Factor Delivery for Bone Tissue Engineering
2001
Cost-Effectiveness of Preventing Hip Fracture in the General Female Population
2001
The Antiparasitic Moxidectin: Safety, Tolerability, and Pharmacokinetics in Humans
2003
The pathophysiology of cigarette smoking and cardiovascular disease
2004 Standout
Migraine — Current Understanding and Treatment
2002 Standout
Ten Year Probabilities of Osteoporotic Fractures According to BMD and Diagnostic Thresholds
2001
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
How do you feel — now? The anterior insula and human awareness
2008 Standout
Effect and Offset of Effect of Treatments for Hip Fracture on Health Outcomes
1999
Physiology of Local Renin-Angiotensin Systems
2006 Standout
tBuLi‐Mediated One‐Pot Direct Highly Selective Cross‐Coupling of Two Distinct Aryl Bromides
2015 StandoutNobel
Biologic, histologic and densitometric effects of oral risedronate on bone in patients with multiple myeloma
1994
Down‐regulation of amygdala preprotachykinin A mRNA but not3H‐SP receptor binding sites in subjects affected by mood disorders and schizophrenia
2005
Ghrelin: Structure and Function
2005 Standout
Losartan renography for the detection of renal artery stenosis: comparison with captopril renography and evaluation of dose and timing
2005
Helminth infections: the great neglected tropical diseases
2008 Standout
Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers †
2007
Epidemiology and outcomes of osteoporotic fractures
2002 Standout
Denosumab and bisphosphonates: Different mechanisms of action and effects
2010
Growth Hormone Secretagogues Stimulate the Hypothalamic-Pituitary-Adrenal Axis and Are Diabetogenic in the Zucker Diabetic Fatty Rat1
1997
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
Fluorine in medicinal chemistry
2007 Standout
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Brief Communication: Sleep Curtailment in Healthy Young Men Is Associated with Decreased Leptin Levels, Elevated Ghrelin Levels, and Increased Hunger and Appetite
2004 Standout
Safety, Tolerability and Pharmacokinetics of BIBN 4096 BS, the First Selective Small Molecule Calcitonin Gene-Related Peptide Receptor Antagonist, Following Single Intravenous Administration in Healthy Volunteers
2004
A Preprandial Rise in Plasma Ghrelin Levels Suggests a Role in Meal Initiation in Humans
2001 Standout
Capturing Magnesium Ions via Microfluidic Hydrogel Microspheres for Promoting Cancellous Bone Regeneration
2021 Standout
The Hitchhiker’s Guide to Flow Chemistry
2017 Standout
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
2010 Standout
The Medicinal Chemist’s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates
2011 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Coronary Side-Effect Potential of Current and Prospective Antimigraine Drugs
1998
Activation of the Hypothalamo-Pituitary-Adrenal Axis by the Growth Hormone (GH) Secretagogue, GH-Releasing Peptide-6, in Rats
1997
Neurokinin antagonists and their potential role in treating depression and other stress disorders
2004
Structural and Biochemical Studies of a Fluoroacetyl-CoA-Specific Thioesterase Reveal a Molecular Basis for Fluorine Selectivity
2010 StandoutNobel
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Bradykinin Contributes to the Vasodilator Effects of Chronic Angiotensin-Converting Enzyme Inhibition in Patients With Heart Failure
2001
Interactions between Clinically Used Bisphosphonates and Bone Mineral: from Coordination Chemistry to Biomedical Applications and Beyond
2018
Endothelial Dysfunction, Impaired Endogenous Fibrinolysis, and Cigarette Smoking
1999
Guidelines for assessment of bone microstructure in rodents using micro–computed tomography
2010 Standout
Aromatic Trifluoromethylation with Metal Complexes
2011 Standout
Visible Light Photoredox Catalysis with Transition Metal Complexes: Applications in Organic Synthesis
2013 Standout
Single-Dose Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Cisplatin Therapy: Randomized, Double-Blind Study Protocol—EASE
2011
Visible‐Light Photocatalysis: Does It Make a Difference in Organic Synthesis?
2018 Standout
Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin
2004
Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteers
1999
Triptans (Serotonin, 5-HT1B/1D Agonists) in Migraine: Detailed Results and Methods of A Meta-Analysis of 53 Trials
2002
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Peptidomimetic Regulation of Growth Hormone Secretion
1997
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
1999 StandoutNature
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Neuroendocrine Control of Growth Hormone Secretion
1999
Works of David Sciberras being referenced
PHARMACOKINETICS AND FOOD INTERACTION OF MK-462 IN HEALTHY MALES
1996
Initial human experience with MK-462 (rizatriptan): a novel 5=HTIDagonist
1997
Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects
2002
Substance P‐induced vasodilatation is mediated by the neurokinin type 1 receptor but does not contribute to basal vascular tone in man
1999
Assessment of MK-467, a peripheral α2-adrenergic receptor antagonist, with intravenous clonidine
1991
Comparison of Angiotensin-Converting Enzyme Inhibition with Angiotensin II Receptor Antagonism in the Human Forearm
1993
Repeatability of local forearm vasoconstriction to endothelin‐1 measured by venous occlusion plethysmography
2002
Intra‐arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerability
1997
Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant
2004
Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects
2002
L-692,429, a nonpeptide growth hormone (GH) secretagogue, reverses glucocorticoid suppression of GH secretion.
1994
Elimination and Biochemical Responses to Intravenous Alendronate in Postmenopausal Osteoporosis
1997
Effects of five daily 1 h infusions of alendronate in paget's disease of bone
1992
Initial human experience with MK‐462 (rizatriptan): a novel 5=HTID agonist
1997
Clinical pharmacology of angiotensin and bradykinin in human forearm vasculature.
1993